Bo Zhai | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Bo Zhai | Healthcare Data Analysis | Best Researcher Award

The Fourth Hospital of Harbin Medical University, China

Author Profile

Scopus

Early Academic Pursuits 📚

Dr. Bo Zhai, a highly respected Chief Physician and Associate Professor at The Fourth Hospital of Harbin Medical University, began his academic journey with a focus on hepatology and cell biology. After earning his MD, Dr. Zhai pursued advanced training as a Postdoctoral Fellow and later became a Fellow of the American College of Surgeons (FACS). His early academic work laid the foundation for his ongoing contributions to liver cancer research, particularly in the realm of hepatocellular carcinoma (HCC).

Professional Endeavors 🏥

Dr. Zhai has had a distinguished professional career, having served as a visiting scholar at the Liver Research Center of Brown University in the USA, sponsored by the National Foreign Experts Bureau. His work on liver cancer has been pivotal in understanding the complexities of HCC, a disease known for its resistance to conventional therapies like sorafenib. His international experience has broadened his research scope and enriched his academic and clinical expertise.

Contributions and Research Focus 🧬

Dr. Zhai’s primary research focus is on hepatocellular carcinoma (HCC), particularly how ASPH (Aspartate β-hydroxylase) influences cell death and contributes to chemoresistance in HCC. He has discovered that high levels of ASPH in HCC enhance proliferation, migration, and invasion, and also predict worse clinical outcomes for patients undergoing sorafenib treatment. His groundbreaking work suggests that targeting ASPH could break new ground in HCC therapy, overcoming the challenges posed by drug resistance.

Impact and Influence 🌍

Dr. Zhai’s research has had a significant impact on the field of liver cancer research, especially in understanding mechanisms of resistance to conventional cancer therapies. His studies on ASPH in HCC have opened new avenues for therapeutic interventions, providing insights into the role of autophagy, ferroptosis, and cell survival pathways in cancer progression. His work has been published in prestigious journals, including Cancer Letters, and is cited widely, underlining his contribution to the scientific community.

Academic Citations 📈

With an impressive citation index of 17.7, Dr. Zhai’s work is highly regarded in the academic community. His research publications, particularly those related to ASPH and HCC, have made substantial contributions to the understanding of liver cancer biology. His studies have provided valuable insights into the molecular mechanisms behind HCC’s resistance to chemotherapy, paving the way for new therapeutic strategies.

Technical Skills 🔬

Dr. Zhai has a wide range of technical skills, including expertise in molecular biology, cancer cell biology, and animal model studies. His proficiency in studying autophagy, ferroptosis, and tumor metastasis has made him a leader in the field of liver cancer research. Additionally, his experience with gene silencing and knockout models has allowed him to explore new potential targets for cancer treatment.

Teaching Experience 🧑‍🏫

As an Associate Professor, Dr. Zhai has contributed significantly to the education and mentoring of graduate and medical students. He has supervised numerous Master’s students and postdoctoral fellows, passing on his expertise in liver cancer research. His teaching extends beyond the classroom, as he is also involved in sharing his knowledge and findings through academic conferences and seminars.

Legacy and Future Contributions 🌱

Dr. Zhai’s legacy in liver cancer research is already well-established, with his groundbreaking work on ASPH setting the stage for future therapeutic developments. As he continues to pursue innovative approaches in HCC treatment, his research promises to lead to better clinical outcomes for patients battling liver cancer. His future contributions to the field will likely focus on developing targeted therapies that can overcome chemoresistance and improve patient survival rates.

Top Noted Publications 📖

ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma
    • Authors: Jingtao Li, Guocai Zhong, Fengli Hu, Qiushi Lin, Xiaoqun Dong, Bo Zhai
    • Journal: Cancer Letters
    • Year: 2024
Mechanisms of vascular co-option as a potential therapeutic target in hepatocellular carcinoma
    • Authors: Ming-Hao Qi, Jing-Tao Li, Bo Zhai
    • Journal: World Chinese Journal of Digestology
    • Year: 2024
Aspartate-β-hydroxylase as a promising prognostic and therapeutic biomarker for HBV-positive hepatocellular carcinoma
    • Authors: Jingtao Li, Zongwen Wang, Xiaohang Ren, WenYu Liu, Shicong Zeng, Bo Zhai
    • Journal: Research Square
    • Year: 2023
Is hepatic resection always a better choice than radiofrequency ablation for solitary hepatocellular carcinoma regardless of age and tumor size?
    • Authors: Shicong Zeng, Yao Zhang, Zongwen Wang, Qiankun Zhu, Yan Yan, Bo Zhai
    • Journal: Biomolecules & Biomedicine
    • Year: 2023
Identification of risk and prognostic factors for intrahepatic vascular invasion in patients with hepatocellular carcinoma: a population-based study
    • Authors: Shicong Zeng, Zongwen Wang, Qiankun Zhu, Fengli Hu, Lishan Xu, Bo Zhai
    • Journal: Translational Cancer Research
    • Year: 2022

Hao Gao | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Prof. Hao Gao | Healthcare Data Analysis | Best Researcher Award

Jinan University, China

Author Profiles

orcid

Scopus

Research Gate

👨‍🎓 Early Academic Pursuits

Prof. Hao Gao began his academic journey with a strong foundation in natural medicine chemistry. He received his PhD from Shenyang Pharmaceutical University in 2005, focusing on the chemistry of natural medicines. This early academic work set the stage for his future contributions to the field of Traditional Chinese Medicine (TCM). After completing his doctorate, he further honed his expertise through postdoctoral training at Tsinghua University (2006-2008), a renowned institution that significantly influenced his approach to scientific research and innovation.

💼 Professional Endeavors and Leadership

Prof. Gao’s professional trajectory has been marked by leadership roles that have shaped his career and the direction of his research. In 2008, he joined the Institute of Traditional Chinese Medicine & Natural Products at Jinan University as a faculty member. Since 2013, he has been a professor at the university and, in 2016, assumed the position of Head of the Institute of Traditional Chinese Medicine & Natural Products. In 2020, he expanded his administrative responsibilities by taking on the role of Director of the Science and Technology Department at Jinan University. Prof. Gao’s leadership has been pivotal in fostering multidisciplinary collaborations and advancing research initiatives in natural medicine chemistry.

🔬 Contributions and Research Focus

Prof. Gao’s research is primarily centered on natural medicine chemistry, with a particular focus on the active compounds and technological advancements related to Traditional Chinese Medicine (TCM). His work is dedicated to exploring under-researched medicinal materials like Lycium barbarum, Angelica sinensis, and Ophiocordyceps sinensis, which are central to TCM practices. Prof. Gao has made significant strides in identifying bioactive substances and developing novel drugs derived from TCM. Notably, his research has led to the discovery of four classes of lead compounds for anti-dementia drugs, all characterized by independent intellectual property rights.

🌍 Impact and Influence

Prof. Gao’s impact extends beyond academia, with substantial contributions to the modernization of TCM and drug development. His collaborations with international experts, such as Professor Ikuro Abe from the University of Tokyo, have facilitated the establishment of the International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, a joint initiative between China’s Ministry of Education and Jinan University. This partnership exemplifies Prof. Gao’s influence on global TCM research and highlights his role in pushing the boundaries of natural product-based drug development.

📚 Academic Citations and Recognition

Prof. Gao’s research has gained widespread recognition, reflected in his 4100 citations across various SCI journals. His work has significantly contributed to the advancement of natural medicine chemistry and TCM, making him a highly influential figure in the field. His numerous publications, with 195 journal articles and one book published, continue to shape research in TCM and pharmacology. Moreover, his leadership as an editor for the China Section of the Journal of Natural Medicines and as an editorial board member for Acta Pharmaceutica Sinica B highlights his prominence in the academic community.

🛠️ Technical Skills and Innovations

Prof. Gao’s technical expertise spans various critical areas, including the extraction, isolation, and characterization of bioactive compounds from TCM. His innovations in pharmacodynamic constituents of TCM have contributed to the discovery of novel drug candidates, some of which are in the process of patenting. With over 71 patents published or pending, Prof. Gao stands at the forefront of translating TCM practices into scientifically validated therapeutic solutions. His lab continues to focus on critical technologies that aim to enhance the efficacy and safety of TCM-derived medicines.

👩‍🏫 Teaching Experience

In addition to his research, Prof. Gao has been an integral part of the academic community at Jinan University, mentoring and guiding students in the fields of pharmacology and natural medicine chemistry. His teaching philosophy integrates cutting-edge research with practical applications in TCM, ensuring that his students are well-equipped to pursue careers in both academia and industry. As a mentor, Prof. Gao has inspired numerous graduate students and postdoctoral researchers, many of whom have gone on to make their own contributions to TCM and drug development.

🌱 Legacy and Future Contributions

Prof. Gao’s legacy is built on his pioneering work in natural medicine chemistry and the modernization of Traditional Chinese Medicine. His research continues to influence the field, with ongoing projects that promise to uncover more bioactive compounds and therapeutic agents. As his career progresses, Prof. Gao remains committed to advancing TCM through innovation and interdisciplinary collaboration. His future work will likely expand the global recognition of TCM-based drugs, pushing the boundaries of natural product drug discovery and pharmacology for the betterment of human health.

🌟 Professional Memberships and Editorial Roles

Prof. Gao is an active member of the China Association of Chinese Medicine, where he serves as Vice Chairperson of the Youth Work Committee. His role in professional societies and editorial boards, including his editorial positions in high-impact journals, underscores his authority in the fields of natural products and biosynthesis. His leadership extends to guiding the next generation of researchers and practitioners in these fields.

📖 Top Noted Publications 

Functional and structural dissection of glycosyltransferases underlying the glycodiversity of wolfberry-derived bioactive ingredients lycibarbarspermidines
    • Authors: Li, S.-Y., Wang, G.-Q., Long, L., Abe, I., Gao, H.
    • Journal: Nature Communications
    • Year: 2024
Identification of three novel P450 enzymes involved in the oxidative modification of a newly discovered fusicoccane diterpene
    • Authors: Dong, L., Liu, J.-Y., Wang, G.-Q., Hu, D., Gao, H.
    • Journal: Bioorganic Chemistry
    • Year: 2024
Targeted Discovery of a Natural ortho-Quinone Methide Precursor and Green Generation of Its Oligomers
    • Authors: Wang, X.-X., Deng, B.-Q., Ouyang, Z.-Q., Yao, X.-S., Gao, H.
    • Journal: Journal of Natural Products
    • Year: 2024
A Functional Switch Between Asperfumene and Fusicoccadiene Synthase and Entrance to Asperfumene Biosynthesis through a Vicinal Deprotonation-Reprotonation Process
    • Authors: Liu, J.-Y., Lin, F.-L., Taizoumbe, K.A., Gao, H., Dickschat, J.S.
    • Journal: Angewandte Chemie – International Edition
    • Year: 2024
Mechanistic characterisation of a fungal fusicoccane-type diterpene synthase involved in the biosynthesis of talaro-7,13-diene
    • Authors: Lin, F.-L., Taizoumbe, K.A., Wang, Y.-X., Gao, H., Dickschat, J.S.
    • Journal: Organic and Biomolecular Chemistry
    • Year: 2024

Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Posted on by ScienceFather

Dr. Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Institut Pasteur Algérie, Algeria

Author Profile

🎓 Early Academic Pursuits

Dr. Tahar Kernif’s academic journey began in 2004 when he completed his Doctorate in Veterinary Science at the École Nationale Vétérinaire d’Alger, where he conducted a comparative study on treatments for canine Leishmaniasis. This research laid the foundation for his future work in veterinary parasitology. Dr. Kernif then pursued a Magistère in Parasitology at the same institution, focusing on zoonotic diseases and vectors, which further honed his expertise in vector-borne infections. These early academic achievements earned him distinction and sparked his lifelong commitment to studying infectious diseases.

🧑‍🔬 Professional Endeavors

Since 2013, Dr. Kernif has been a Maître de Recherche at the Institut Pasteur d’Alger, where he works on molecular techniques to study parasitic diseases in veterinary science. His research focuses on Protozoa, Helminths, and the molecular ecology of arthropod vectors. He has played an integral role in shaping the institute’s research activities on infectious diseases and environmental health, contributing to key initiatives in the field of veterinary parasitology. Dr. Kernif’s professional work is also marked by collaborations with international research institutions such as CIRAD and IRD, where he has worked on studying arthropod microbiota through meta-proteomics.

🔬 Contributions and Research Focus

Dr. Kernif’s primary research interests lie in Infectious Diseases and Health and Environment, specifically focusing on multi-omics approaches to understanding pathogen behavior. His work spans genomics, metagenomics, and proteomics, applying these techniques to study diseases like leishmaniasis and tick-borne infections. His research includes phylogenetic analysis and bioinformatic modeling, which have contributed significantly to the molecular understanding of parasite-host interactions, providing insights into disease transmission and control strategies.

🌍 Impact and Influence

Dr. Kernif’s contributions extend beyond research, as he is actively involved in national health policy and scientific review boards. He served as associate editor for New Microbes and New Infections and has been a scientific examiner for the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). His work has shaped policies related to biodiversity and environmental health, especially in Algeria, where he is part of the National Expert Working Group for the Libreville Declaration on Health and Environment. His influence on public health and policy is a testament to his broad impact in both scientific and governmental circles.

📚 Academic Cites

Dr. Kernif has authored 35 international publications and contributed to two book chapters, demonstrating his prominent role in infectious disease research. His studies are frequently cited in scientific journals, reflecting his influence in veterinary parasitology and zoonotic diseases. His work in molecular epidemiology and vector-borne pathogens has made a lasting impact on the field and continues to guide contemporary research.

🛠️ Technical Skills

Dr. Kernif is highly proficient in a range of advanced techniques critical to research in parasitology and microbiology. His expertise spans capillary sequencing, next-generation sequencing (NGS), and PCR/qPCR, which are essential for molecular surveillance and unraveling genetic information. He is also skilled in MALDI-TOF Mass Spectrometry, currently in progress, allowing for detailed molecular analysis of pathogens. Additionally, Dr. Kernif utilizes bioinformatics to analyze complex datasets, helping to interpret vast amounts of biological data. His proficiency in meta-proteomics is instrumental in studying the microbiota of arthropods, providing insights into disease mechanisms and transmission. These tools equip Dr. Kernif with the ability to conduct precise and impactful research, advancing our understanding of infectious diseases.

👩‍🏫 Teaching Experience

Throughout his career, Dr. Kernif has shared his expertise through academic mentorship and scientific training. As a researcher at the Institut Pasteur d’Alger, he supervises graduate students and engages in international collaborations to promote knowledge exchange. His teaching and mentorship in the field of veterinary parasitology and infectious diseases continue to shape the next generation of scientists.

🌱 Legacy and Future Contributions

Dr. Kernif’s legacy is marked by his scientific publications, international collaborations, and his influence in shaping research policy in infectious diseases. Moving forward, his research is poised to address emerging health threats, particularly those arising from vector-borne diseases. His continued contributions to global health initiatives and his work on disease surveillance are expected to leave a lasting mark on the fields of veterinary entomology and infectious disease control.

 

📖 Top Noted Publications

Update on tick-borne rickettsioses around the world: a geographic approach
    • Authors: P Parola, CD Paddock, C Socolovschi, MB Labruna, O Medianikov, …
    • Journal: Clinical Microbiology Reviews
    • Year: 2013
Borrelia, Rickettsia, and Ehrlichia species in bat ticks, France, 2010
    • Authors: C Socolovschi, T Kernif, D Raoult, P Parola
    • Journal: Emerging Infectious Diseases
    • Year: 2012
Matrix-assisted laser desorption ionization–time of flight mass spectrometry for rapid identification of tick vectors
    • Authors: A Yssouf, C Flaudrops, R Drali, T Kernif, C Socolovschi, JM Berenger, …
    • Journal: Journal of Clinical Microbiology
    • Year: 2013
Identification of flea species using MALDI-TOF/MS
    • Authors: A Yssouf, C Socolovschi, H Leulmi, T Kernif, I Bitam, G Audoly, L Almeras, …
    • Journal: Comparative Immunology, Microbiology and Infectious Diseases
    • Year: 2014
Rickettsiae of spotted fever group, Borrelia valaisiana, and Coxiella burnetii in ticks on passerine birds and mammals from the Camargue in the south of France
    • Authors: C Socolovschi, P Reynaud, T Kernif, D Raoult, P Parola
    • Journal: Ticks and Tick-Borne Diseases
    • Year: 2012

Wei Liang | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Dr. Wei Liang | Healthcare Data Analysis | Best Researcher Award

Doctorate at East China University of Science and Technology, China

 Author Profile 👨‍🎓

Early Academic Pursuits 🎓

Dr. Wei Liang embarked on his academic journey at East China University of Science and Technology, where he earned his Bachelor’s degree in Engineering (B.E.) in 2020. His interest in Brain-Computer Interfaces (BCI) and Machine Learning became evident during his undergraduate studies, setting the stage for his continued academic success. Currently, he is pursuing his PhD at the same institution, delving deeper into the intersection of neuroscience, computer science, and biomedical engineering. His early education laid a strong foundation for his research in the emerging field of BCI technology.

Professional Endeavors 💼

As a PhD candidate, Wei Liang is already contributing to the rapidly evolving field of Brain-Computer Interfaces, particularly in motor imagery and neural signal processing. His research involves collaboration with prominent experts in the fields of computer science, neuroscience, and biomedical engineering, such as Andrzej Cichocki, Ian Daly, and Brendan Allison. Liang’s professional journey has been shaped by these collaborations, allowing him to gain insights from diverse disciplines, further honing his expertise in BCI.

Contributions and Research Focus 🧠

Wei Liang’s research focuses on advancing Brain-Computer Interface (BCI) technology, particularly in motor imagery and neural signal processing. His work has led to the development of SecNet, a second-order neural network designed to improve motor imagery decoding from electroencephalography (EEG) signals. Liang’s innovative approaches include variance-preserving spatial patterns for EEG signal processing and the use of graph convolutional networks for optimal channel selection. These contributions have enhanced the accuracy and reliability of BCI systems, making them more applicable to real-world scenarios such as stroke rehabilitation and neural engineering.

Impact and Influence 🌍

Wei Liang’s work is making significant strides in improving BCI systems, which have far-reaching applications in medicine, rehabilitation, and human-computer interaction. By optimizing EEG decoding strategies, his research could impact the development of more effective neuroprosthetics and assistive technologies for individuals with motor impairments. His collaboration with leading researchers from around the world further amplifies the global impact of his work, positioning him as a rising star in BCI research.

Academic Citations 📚

Despite being in the early stages of his career, Wei Liang has already made a notable impact on the academic community. His research has led to the publication of five papers, accumulating a total of 14 citations and an h-index of 2. Notable papers include works published in Information Processing & Management, Frontiers in Human Neuroscience, and IEEE Journal of Biomedical and Health Informatics, among others. These publications highlight his contributions to improving BCI systems and their applications.

Technical Skills 🛠️

Wei Liang possesses a strong technical skill set, particularly in the areas of machine learning, neural network architecture, and EEG signal processing. He has expertise in developing novel algorithms for motor imagery decoding, including the use of second-order neural networks and graph convolutional networks. Liang is proficient in various computational tools and programming languages necessary for his research, positioning him as an expert in his field.

Teaching Experience 🏫

Though primarily focused on research, Wei Liang’s academic journey has also included some teaching experience, collaborating with faculty and providing guidance to students. His strong academic background, coupled with his research expertise, allows him to mentor and inspire others in the field of Brain-Computer Interfaces.

Legacy and Future Contributions 🌟

Wei Liang’s research trajectory holds great promise for shaping the future of Brain-Computer Interface technology. His innovative methodologies have the potential to revolutionize how we understand and utilize EEG signals for communication and rehabilitation. In the long term, his contributions could lead to breakthroughs in neuroprosthetics, enhancing the quality of life for individuals with disabilities. With continued dedication and innovation, Liang is on track to leave a lasting legacy in the realm of neuroscience and technology.

Teaching and Mentorship 🧑‍🏫

Although Liang is primarily focused on research, his experiences collaborating with top researchers and participating in academia have enriched his teaching and mentorship skills. His ability to translate complex ideas into understandable concepts makes him an effective communicator, ready to guide the next generation of researchers in the field of BCI.

Awards and Recognition 🏆

Wei Liang has been recognized for his groundbreaking research, publishing in high-impact journals and earning accolades for his contributions to BCI technology. As a promising young researcher, he is poised to receive even greater recognition as his work continues to influence and shape the future of the field.

Top Noted Publications📖

Novel Channel Selection Model Based on Graph Convolutional Network for Motor Imagery
    • Authors: W Liang, J Jin, I Daly, H Sun, X Wang, A Cichocki
    • Journal: Cognitive Neurodynamics
    • Year: 2023
Variance Characteristic Preserving Common Spatial Pattern for Motor Imagery BCI
    • Authors: W Liang, J Jin, R Xu, X Wang, A Cichocki
    • Journal: Frontiers in Human Neuroscience
    • Year: 2023
SecNet: A Second Order Neural Network for MI-EEG
    • Authors: W Liang, BZ Allison, R Xu, X He, X Wang, A Cichocki, J Jin
    • Journal: Information Processing & Management
    • Year: 2025
Multiscale Spatial-Temporal Feature Fusion Neural Network for Motor Imagery Brain-Computer Interfaces
    • Authors: J Jin, W Chen, R Xu, W Liang, X Wu, X He, X Wang, A Cichocki
    • Journal: IEEE Journal of Biomedical and Health Informatics
    • Year: 2024
Leveraging Transfer Superposition Theory for StableState Visual Evoked Potential Cross-Subject Frequency Recognition
    • Authors: X He, BZ Allison, K Qin, W Liang, X Wang, A Cichocki, J Jin
    • Journal: IEEE Transactions on Biomedical Engineering
    • Year: 2024

nader tarabeih | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Dr. nader tarabeih | Healthcare Data Analysis | Best Researcher Award

Dr. nader tarabeih at Ariel University, Israel

👨‍🎓Professional Profile

👨‍🔬 Summary

Dr. Nader Tarabeih is a dedicated researcher and clinician with a focus on genetic epidemiology and musculoskeletal disorders. Currently a postdoctoral researcher at Ariel University, his work centers on understanding inflammation-related biomarkers and their role in spinal pain. With a solid background in nursing, Dr. Tarabeih transitioned to academic research, publishing impactful studies on low back pain, metabolic factors, and their genetic causes.

🎓 Education

Dr. Tarabeih’s educational journey reflects his deep commitment to advancing medical research. He is currently pursuing a Post-doctoral position in Morphological Studies at the Adelson School of Medicine, Ariel University (2023 – Present). Previously, he completed his PhD in Genetic Epidemiology at Tel Aviv University (2018 – 2022), focusing on how blood biochemical factors and body composition affect spinal pain in complex Arab pedigrees. His MSc (2013 – 2016) also at Tel Aviv University examined genetic, demographic, and body composition risk factors for low back pain. Additionally, he holds a BA in Nursing from Tel Aviv University (2006 – 2010).

💼 Professional Experience

Dr. Tarabeih has gained extensive clinical and leadership experience in the healthcare field. He served as Director of Quality and Safety at the Maale HaCarmel Mental Health Center in Haifa, Israel (2020 – 2023). Prior to this, he worked as a Nurse at the same institution (2013 – 2020), where he applied his clinical expertise in a variety of settings, contributing to patient care and safety.

🔧 Technical Skills

Dr. Tarabeih brings a broad set of skills to his research and clinical practice. He is proficient in Genetic Epidemiology, specializing in the analysis of complex pedigrees and genetic risk factors for musculoskeletal disorders. His expertise extends to Biomarker Discovery, where he investigates biomarkers to improve the understanding and management of spinal pain. Additionally, he is skilled in Data Analysis and Clinical Research, focusing on inflammation, metabolic health, and spinal disorders.

👩‍🏫 Teaching Experience

Dr. Tarabeih has been an active contributor to academic discussions and has presented his research at several notable conferences. In 2022, he spoke on systemic biomarkers in degenerative lumbar spinal disorders at the Post-Genome Analysis for Musculoskeletal Biology Conference in Tzfat, Israel. He also presented on low back pain and its genetic and biochemical factors at the International Conference on Spine Disorders in Dubai, UAE (2020), and contributed a poster on genetic risk factors for low back pain at the BIRAX Ageing Conference in London, UK (2018).

🔬 Research Interests

Dr. Tarabeih’s research is driven by a passion for understanding the genetic and environmental causes of musculoskeletal disorders. His primary interests lie in Genetic Epidemiology, particularly in how genetic and lifestyle factors contribute to spinal pain. He is also dedicated to identifying biomarkers for pain-related disabilities and exploring the impact of inflammation and metabolism on musculoskeletal health in diverse populations.

 

📖 Top Noted Publications

Fernando López | Healthcare Data Analysis | Excellence in Research

Posted on by ScienceFather

Assoc Prof Dr. Fernando López | Healthcare Data Analysis | Excellence in Research

Assoc Prof Dr. Fernando López at Hospital Clinico Universitario – Universidad de Valencia, Spain

👨‍🎓  Profile

Early Academic Pursuits 🎓

Dr. Fernando López began his academic journey at the Universidad de Cádiz, where he earned his Licenciatura in Medicine and Surgery from 1987 to 1993. His dedication led him to further his education through the Official Doctoral Program in Medicine and Surgery at the Universitat de València, culminating in a doctoral degree awarded with “Sobresaliente cum laude” in 2001.

Professional Endeavors 🏥

Dr. López completed his specialized training in General Surgery and Digestive System Surgery via the MIR program at the Hospital Clínico Universitario de Valencia from 1995 to 2000. He currently serves as an Associate Professor in the Department of Surgery at the Universitat de València, where he has been actively involved since 2011.

Contributions and Research Focus 🔍

Dr. López has made significant contributions to surgical research, particularly in the context of the COVID-19 pandemic. He is a co-author of several influential articles addressing surgical risks and outcomes during this crisis, with particular emphasis on the integration of machine learning for risk prediction. His work has been published in leading journals, reflecting his commitment to advancing surgical practices.

Impact and Influence 🌍

His research has garnered considerable attention, with publications in both national and international journals totaling 35, including articles in high-impact publications such as the British Journal of Surgery. His collaborative work with the COVIDSurg Collaborative has had a meaningful impact on surgical protocols during the pandemic.

Academic Cites 📚

Dr. López’s research has resulted in a notable cumulative impact factor of 76.697 across his indexed publications, illustrating the significant reach and influence of his work in the academic community.

Technical Skills ⚙️

As an experienced surgeon, Dr. López possesses a robust set of technical skills, particularly in advanced trauma and emergency care. He has been involved in teaching various advanced trauma life support courses and has contributed to international workshops, underscoring his proficiency and commitment to surgical education.

Teaching Experience 👨‍🏫

In addition to his clinical practice, Dr. López has extensive teaching experience, having tutored 35 residents in General Surgery and Digestive Surgery. He has organized and led numerous courses and seminars, including advanced trauma support training, reflecting his passion for educating the next generation of surgeons.

Legacy and Future Contributions 🌱

Looking ahead, Dr. López aims to continue his research in surgical safety and education, leveraging his experience and expertise to foster advancements in the field. His ongoing commitment to mentoring residents and collaborating on impactful research will undoubtedly leave a lasting legacy in the surgical community.

📖 Top Noted Publications

 

Characteristics of gastrointestinal stromal tumors associated to other tumors, 2024

Characteristics of gastrointestinal stromal tumors associated to other tumors, 2024

Glasbey, J. C., Nepogodiev, D., COVIDSurg Collaborative. (2021). Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. British Journal of Surgery, 6, pp. 1-19.

LUCENTUM Project Researchers. (2021). Simplified risk-prediction for benchmarking and quality improvement in emergency general surgery: Prospective, multicenter, observational cohort study. International Journal of Surgery, 97, pp. 1-35.

Glasbey, J. C., Nepogodiev, D., COVIDSurg Collaborative. (2021). Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. British Journal of Surgery, 6, pp. 1-19.

Natalia Vallianou | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Dr. Natalia Vallianou | Healthcare Data Analysis | Best Researcher Award

Dr. Natalia Vallianou at Evangelismos General Hospital, Greece

👨‍🎓 Profiles

📚 Early Academic Pursuits

Dr. Natalia Vallianou began her academic journey at the University of Thessaly, where she earned her degree in Medicine with honors from 1991 to 1997. During her medical training, she built a strong foundation in various medical disciplines, which prepared her for her specialization in infectious diseases. Following graduation, she pursued a Master of Science (MSc) in Infectious Diseases at the University of Athens from 1998 to 2000, gaining critical knowledge essential for her future endeavors. Dr. Vallianou completed her residency in Internal Medicine between 1999 and 2004, honing her clinical skills before earning her PhD with research focused on antibiotic resistance in Staphylococci.

🏥 Professional Endeavors

Currently, Dr. Vallianou serves as the Director of the First Department of Internal Medicine at Sismanogleio General Hospital in Athens, a role she has held since January 2024. Previously, she worked as a Consultant in Internal Medicine at Evangelismos General Hospital from July 2009 to January 2024, where she influenced patient care and clinical training. Her earlier experience at Polikliniki General Hospital further solidified her expertise. Additionally, her work at the Laboratory of Infectious Diseases involved critical research and patient care, allowing her to merge clinical practice with scientific inquiry.

🔬 Contributions and Research Focus

Dr. Vallianou’s research primarily focuses on infectious diseases, antimicrobial resistance, and clinical microbiology. She has authored an impressive 155 publications in international scientific journals, with 124 indexed in PubMed. Her research has appeared in high-impact journals such as Seminars in Cancer Biology and Clinical Microbiology and Infection. Dr. Vallianou has presented at 151 international and Hellenic congresses and serves as a reviewer for prestigious medical journals, reflecting her significant contributions to the field.

🏆 Accolades and Recognition

Throughout her career, Dr. Vallianou has received various accolades for her contributions to medicine and research. Her publications in high-impact journals and active participation in international congresses have established her as a leading voice in infectious diseases. Recognized for her mentorship, she has influenced many medical students and residents, and her proficiency in English and French has enabled her to collaborate globally.

🌍 Impact and Influence

Dr. Vallianou’s impact goes beyond her clinical and research achievements. As a leader in her field, she has influenced practices among healthcare professionals and inspired new generations to prioritize research and evidence-based medicine. Her focus on antimicrobial resistance is particularly relevant, as she contributes to strategies aimed at combating this pressing public health challenge.

🔮 Legacy and Future Contributions

As Dr. Vallianou continues her career, her legacy will be marked by her dedication to improving patient outcomes and advancing the field of infectious diseases. She aims to explore innovative approaches to treatment and prevention of antimicrobial resistance, fostering collaboration between clinicians and researchers to enhance infectious disease management. Her influence will undoubtedly continue to shape the medical landscape for years to come.

📖  Top Noted Publications
Serum and urinary levels of MIF, CD74, DDT and CXCR4 among patients with type 1 diabetes mellitus, type 2 diabetes and healthy individuals: Implications for further research
    • Authors: Katia Mangano, Aristidis Diamantopoulos, Natalia G. Vallianou, Theodora Stratigou, Fotis Panagopoulos, Dimitris Kounatidis, Maria Dalamaga, Paolo Fagone, Ferdinando Nicoletti
    • Journal: Metabolism Open
    • Year: 2024
The role of kidney biopsy in deciphering diabetic versus non-diabetic origin of kidney disease among patients with type 2 diabetes mellitus and nephrotic range proteinuria: A retrospective study
    • Authors: Efstratios Kardalas, Aggeliki Paikopoulou, Dimitra A. Vassiliadi, Dimitris Kounatidis, Natalia G. Vallianou, Christine Vourlakou, Irene Karampela, Maria Dalamaga, Marinella Tzanela, Theodora Stratigou
    • Journal: Metabolism Open
    • Year: 2024
Kinetics of the Lactate to Albumin Ratio in New Onset Sepsis: Prognostic Implications
    • Authors: Irene Karampela, Dimitris Kounatidis, Natalia G. Vallianou, Fotis Panagopoulos, Dimitrios Tsilingiris, Maria Dalamaga
    • Journal: Diagnostics
    • Year: 2024
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
    • Authors: Dimitris Kounatidis, Nikolaos Tentolouris, Natalia G. Vallianou, Iordanis Mourouzis, Irene Karampela, Theodora Stratigou, Eleni Rebelos, Marina Kouveletsou, Vasileios Stamatopoulos, Eleni Tsaroucha et al.
    • Journal: Metabolites
    • Year: 2024
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
    • Authors: Natalia Vallianou, Dimitris Kounatidis, Sotiria Psallida, Nikolaos Vythoulkas-Biotis, Andreas Adamou, Tatiana Zachariadou, Sofia Kargioti, Irene Karampela, Maria Dalamaga
    • Journal: Metabolites
    • Year: 2024

Chung-Chieh Hung | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Dr. Chung-Chieh Hung | Healthcare Data Analysis | Best Researcher Award

Doctorate at Chung Shan Medical University Hospital, Taiwan

👨‍🎓 Profile

🩺 Current Position

Dr. Chung-Chieh Hung is the Chief of the Subdivision of Prevention of Addictive Diseases at the Department of Psychiatry, China Medical University Hospital, a role he has held since 2020. In this capacity, he leads efforts to address addiction-related disorders and improve treatment strategies.

🧠 Specialties

Dr. Hung specializes in various areas of psychiatry, including General Psychiatry, where he treats conditions such as anxiety disorders, sleep disorders, depression, bipolar disorder, schizophrenia, and dementia. His expertise also extends to Forensic Psychiatry, where he handles cases related to domestic violence and sexual offenders. Additionally, he is well-versed in Addiction Medicine and Judicial Psychiatric Evaluation, providing comprehensive assessments and treatments for addiction and legal cases.

🎓 Education

Dr. Hung obtained his Bachelor of Medicine from Chang Gung University. He furthered his education with a Master of Medical Science and a Doctor of Medical Science from China Medical University. Additionally, he holds a Master of Law from National Chung Hsing University and is currently pursuing a PhD in Law at National Chengchi University.

🏥 Professional Experience

Dr. Hung began his career as a Resident in Pediatric Internal Medicine at Linkou Chang Gung Memorial Hospital. He then served as a Chief Resident and Research Physician in the Department of Psychiatry at China Medical University Hospital before becoming an Attending Psychiatrist. From 2020 to 2023, he was the Director of the Division of Addiction Prevention.

📰 Academic Research and Publications

Dr. Hung has made significant contributions to psychiatry through his publications in renowned journals like JAMA Psychiatry and Frontiers in Bioengineering and Biotechnology. His research includes studies on Betel-Quid Use Disorder and the effects of antidepressants on betel-quid use, among others.

🌍 Oral Presentations & Posters

He has presented his research at various prestigious conferences, including the World Psychiatry Association Regional Meeting and international symposia on psychiatry and addiction.

🧩 Research Projects

Dr. Hung has led several research projects funded by the Ministry of Health and Welfare, focusing on problematic alcohol use, addiction treatment services, and methadone treatment quality improvement.

🏛️ Professional Roles in Government and Professional Organizations

He serves on the Domestic Violence Pre-Trial Assessment Panel for the Taichung City Health Bureau and is a Medical Dispute Initial Assessment Personnel for the Medical Quality Advancement Association. He is also an expert on sexual assault prevention laws for the Ministry of Health and Welfare and an external inspector for the Ministry of Justice’s Correctional Services.

⚖️ Forensic Psychiatry Evaluations

Dr. Hung has provided expert forensic psychiatric evaluations in various high-profile legal cases, including those involving sexual autonomy, violent crimes, and drug-related offenses.

🌟 Victim Assessments

He has also conducted assessments for victims of domestic violence and sexual crimes, offering crucial insights into victim credibility and trauma evaluation.

📖 Publications

Association between Single Nucleotide Polymorphisms in Monoamine Oxidase and the Severity of Addiction to Betel Quid
    • Authors: Chung-Chieh Hung, Ying-Chin Ko, Chia-Min Chung
    • Journal: Current Issues in Molecular Biology
    • Year: 2024
Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
    • Authors: Chung-Chieh Hung, Chieh-Hsin Lin, Hsien-Yuan Lane
    • Journal: International Journal of Molecular Sciences
    • Year: 2021
Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry
    • Authors: Chieh-Hsin Lin, Hung Su, Chung-Chieh Hung, Hsien-Yuan Lane, Jentaie Shiea
    • Journal: Molecules
    • Year: 2021
An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
    • Authors: Eugene Lin, Chieh-Hsin Lin, Chung-Chieh Hung, Hsien-Yuan Lane
    • Journal: Frontiers in Bioengineering and Biotechnology
    • Year: 2020
Effect of Antidepressants for Cessation Therapy in Betel-Quid Use Disorder: A Randomised, Double-Blind, Placebo-Controlled Trial
    • Authors: Chung-Chieh Hung, Chien-Hung Lee, Albert Min-Shan Ko, Chi-Pin Lee, Ying-Chin Ko
    • Journal: Epidemiology and Psychiatric Sciences
    • Year: 2020
Antidepressant-Induced Reduction in Betel-Quid Use in Patients with Depression: A Pioneer Clinical Study
    • Authors: Chung-Chieh Hung, Chien-Hung Lee, Chia-Min Chung, Hsien-Yuan Lane, Ying-Chin Ko
    • Journal: Medicine (Baltimore)
    • Year: 2020
Variants in FAT1 and COL9A1 Genes in Male Population with or without Substance Use to Assess the Risk Factors for Oral Malignancy
    • Authors: Chia-Min Chung, Chung-Chieh Hung, Chieh-Hsin Lin, Kuan-Tsa Yeh, Ying-Chin Ko
    • Journal: PLoS ONE
    • Year: 2019
Association of DSM-5 Betel-Quid Use Disorder with Oral Potentially Malignant Disorder in 6 Betel-Quid-Endemic Asian Populations
    • Authors: Chien-Hung Lee, Albert Min-Shan Ko, Frances M Yang, Chung-Chieh Hung, Saman Warnakulasuriya, Salah Osman Ibrahim, Rosnah Binti Zain, Ying-Chin Ko
    • Journal: JAMA Psychiatry
    • Year: 2018
Hypothyroidism May Exacerbate Valproate-Related Hyperammonemic Delirium
    • Authors: Chung-Chieh Hung, Chieh-Hsin Lin, Hsien-Yuan Lane
    • Journal: BioMedicine (Netherlands)
    • Year: 2016

Oluwakemi Abuka | Healthcare Data Analysis | Excellence in Research

Posted on by ScienceFather

Ms. Oluwakemi Abuka | Healthcare Data Analysis | Excellence in Research

 Ms. Oluwakemi Abuka at Devereux Direct Care Organization, United States

 Profile

Google Scholar Profile

🎓 Education Background

Oluwakemi Abuka earned her Master of Science in Sociology from the University of Ibadan in 2011, following a Bachelor of Science in Sociology from Bowen University in 2007. Her educational journey provided a solid foundation in sociological theories and research methodologies, fueling her career in administrative and behavioral health roles. 📚🎓

🏛️ Professional Experience

With over 7.5 years of experience, Oluwakemi has served as an Administrative Officer in Ogun State Civil Service, focusing on vendor management, budget planning, and conflict resolution among community leaders. Currently, she is a Senior Healthcare Professional at Devereux Advanced Behavioral Health, where she supports individuals’ well-being and ensures their safe, productive integration into their communities. 👩‍💼🌟

📝 Research Interests

Oluwakemi’s research centers on adolescent mental health, substance abuse, and public health interventions. Her work explores the impact of social media on substance abuse and integrates technology to enhance mental health outcomes. 🧠🔬

📜 Publications and Media

Her research has been featured in peer-reviewed journals and notable media outlets, emphasizing her expertise in adolescent behavioral health and the socio-cultural impacts of substance abuse. Articles include studies on adolescent mental health innovations and substance abuse’s role in the digital age. 📖📰

🏅 Certifications and Training

Oluwakemi holds several certifications, including Adult First Aid/CPR/AED from the American Red Cross and various behavioral health training from Devereux. Her professional development also includes workshops on human resources management and administrative skills. 🏅🎓

🌐 Professional Memberships

She is a member of the American Sociological Association, reflecting her commitment to advancing the field of sociology and behavioral health through active participation in professional communities. 🌐🤝

📖 Publication

Enhancing adolescent mental health outcomes through integrated technology (AI) innovations in the United States

    • Authors: OAAJSA Ajibola O Adesina
    • Journal: International Journal of Advanced Psychiatric Nursing
    • Year: 2024

Occupation Injuries among Health Care Workers in Selected Hospitals in Ogbomosho, Oyo State

    • Authors: A Ajibola, OA Abuka
    • Journal: International Journal of Innovative Science and Research Technology
    • Year: 2024

Substance abuse among young adults, and the contributing factors of social media in the United States

    • Authors: OA Abuka, AO Adesina
    • Journal: World Journal of Biology Pharmacy and Health Sciences
    • Year: 2024

Bureaucracy and Level of Efficiency among Professional Staff of Federal Neuropsychiatric Hospital Aro, Abeokuta, Ogun State

    • Authors: Oluwakemi Abuka
    • Journal: Abeokuta, Ogun State (May 12, 2015)
    • Year: 2015

Keeley Rigby | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Mrs. Keeley Rigby, Healthcare Data Analysis, Best Researcher Award

Mrs. Keeley Rigby at Sheffield Hallam University, United Kingdom

Professional Profile

Scopus Profile
Orcid Profile

🌟Summary

Keeley Louise Rigby (Rosbottom) is a seasoned Therapeutic Radiographer with a distinguished career in radiotherapy and oncology. She currently serves as the Course Leader for the Therapeutic Radiography Degree Apprenticeship and Senior Lecturer in Radiotherapy & Oncology at a prestigious institution. Keeley is recognized for her expertise in teaching and research, particularly in areas like sarcomas, digestive systems, and endocrine systems. Her commitment to enhancing patient care and survivorship is evident through her leadership in projects like the CELEBRATE study on the impact of the end of treatment bell in radiotherapy.

🎓Education

Keeley Louise Rigby (Rosbottom) holds a Master of Science degree in Radiotherapy & Oncology in Practice, earned from Sheffield Hallam University in September 2015. Her academic journey also includes a Postgraduate Certificate in Learning and Teaching in Higher Education, completed in April 2014, and a Postgraduate Diploma in Radiotherapy & Oncology in Practice with Distinction, attained from the same institution in September 2008. She initially pursued her passion for medical sciences, earning a Bachelor of Science with Honors from the University of Leeds in June 2005. Keeley’s educational achievements have equipped her with a solid foundation to excel in her roles as Course Leader and Senior Lecturer in Radiotherapy & Oncology, where she continues to integrate cutting-edge research and teaching methodologies into her practice.

💼 Professional Experience

Keeley has held progressive roles in radiotherapy, starting as a Radiotherapy Practitioner Radiographer and advancing to her current positions. She has extensive experience in clinical practice, education, and research, contributing significantly to the field through innovative teaching methods and scholarly activities.

🔬 Research Interests

Her research interests encompass improving patient quality of life, exploring innovative radiotherapy techniques, and advancing education in therapeutic radiography. Keeley has actively participated in projects like the SuPPORT 4 All and CELEBRATE studies, focusing on enhancing patient outcomes and experiences during and after radiotherapy treatment.

📖 Publication Top Noted